NeuBase Therapeutics Inc (NASDAQ:NBSE) gain 3.50% – Is It right time to buy?
NeuBase Therapeutics Inc (NBSE) saw an uptrend of 3.50% in the recent trading with $0.45 being its most recent. The current price level -91.67% lower than the highest price of $5.40 marked by the stock while trading over the past 52-weeks, whereas it is 8.41% higher than the lowest price of $0.41 the company dropped […]
